Effect of Matrices on Serum Fructose.
Effects of the Food Matrix on Serum Fructose Peaks
1 other identifier
interventional
23
1 country
1
Brief Summary
Epidemiological evidence is accumulating that a high consumption of added sugars is associated with metabolic diseases such as non-alcoholic fatty liver disease and type 2 diabetes. Fructose, one of the principal added sugars, is believed to be the most disadvantageous sugar. Data from a large population-based cohort demonstrated that fructose intake from fruit juice and sugar-sweetened beverages, but not whole fruits, is associated with higher intrahepatic lipid content. A study in mice demonstrated that fast fructose exposure resulted in higher intrahepatic lipid content than slow fructose exposure. The food matrix, i.e. the complex spatial organisation of and interactions between nutrients, may account for the fast versus slow fructose exposure and subsequent health consequences. Therefore the investigators aim to investigate the role of the fructose matrices on serum fructose peaks. The investigators hypothesize that liquid fructose matrices will cause higher serum fructose peaks in comparison to solid fructose matrices. Objective: To quantify serum fructose peaks within 150 minutes following intake of fructose-containing matrices.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 15, 2022
CompletedFirst Submitted
Initial submission to the registry
March 28, 2023
CompletedFirst Posted
Study publicly available on registry
April 24, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2024
CompletedFebruary 20, 2025
February 1, 2025
2 years
March 28, 2023
February 18, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in serum fructose between peak and baseline
Time points 0, 15, 30, 45, 60, 75, 90, 105, 120, 135 and 150 minutes following consumption of the food product.
Secondary Outcomes (2)
Blood pressure
Time points 0, 15, 30, 45, 60, 75, 90, 105, 120, 135 and 150 minutes following consumption of the food product.
Serum uric acid
Time points 0, 15, 30, 45, 60, 75, 90, 105, 120, 135 and 150 minutes following consumption of the food product.
Study Arms (4)
Food product 1.
EXPERIMENTAL\[x\] gr apple containing 20 gr fructose as measured with an enzymatic method. Administered one time.
Food product 2.
EXPERIMENTAL\[x\] gr mashed apple containing 20 gr fructose as measured with an enzymatic method. Administered one time.
Food product 3.
EXPERIMENTAL\[x\] ml apple juice containing 20 gr fructose as measured with an enzymatic method. Administered one time.
Food product 4.
EXPERIMENTAL20 gr of fructose powder dissolved in 300 ml of water. Administered one time.
Interventions
20g fructose in \[x\] g of mashed apple
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years.
- Body mass index (BMI) ≥18.5 kg/m2 and \<25 kg/m2
You may not qualify if:
- Pregnancy.
- Drugs and/or alcohol abuse.
- Diagnosis of diabetes mellitus.
- (History of) gastrointestinal and/or liver disease.
- (History \[\< 5 years\] of) cancer (excluding basal cell carcinoma)
- Allergy to one of the used food products in the study.
- Inability to provide written informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Academic Hospital Maastricht
Maastricht, 6229 HX, Netherlands
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 28, 2023
First Posted
April 24, 2023
Study Start
December 15, 2022
Primary Completion
December 20, 2024
Study Completion
December 20, 2024
Last Updated
February 20, 2025
Record last verified: 2025-02